Genetics

Episodes 1-16 of 19

Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH
Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH
Project Oncology®
Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH
- Ryan Quigley
- Kathrin M. Bernt, MD
- Rushabh Mehta, BS
- Fatemeh Alikarami
Beyond the Cure: Addressing Psychosocial Needs in Gene Therapy for SCD
Beyond the Cure: Addressing Psychosocial Needs in Gene Therapy for SCD
Project Oncology®
Beyond the Cure: Addressing Psychosocial Needs in Gene Therapy for SCD
- Victoria Coleman-Cowger, PhD
Predicting Prognosis in DLBCL: The Role of Immune-Related Gene Signatures
Predicting Prognosis in DLBCL: The Role of Immune-Related Gene Signatures
Project Oncology®
Predicting Prognosis in DLBCL: The Role of Immune-Related Gene Signatures
Early Liquid Biopsy in Advanced Lung Cancer: Real-World Data Suggest Targeted Gains
Early Liquid Biopsy in Advanced Lung Cancer: Real-World Data Suggest Targeted Gains
Project Oncology®
Early Liquid Biopsy in Advanced Lung Cancer: Real-World Data Suggest Targeted Gains
Expanding the Risk Profile: Genetic Insights Into Lung Cancer in Non-Smokers
Expanding the Risk Profile: Genetic Insights Into Lung Cancer in Non-Smokers
Project Oncology®
Expanding the Risk Profile: Genetic Insights Into Lung Cancer in Non-Smokers
- Paola Marignani, PhD, EMBA
Unlocking Tumor Complexity: Single-Cell RNA Sequencing in Lung Cancer
Unlocking Tumor Complexity: Single-Cell RNA Sequencing in Lung Cancer
Project Oncology®
Unlocking Tumor Complexity: Single-Cell RNA Sequencing in Lung Cancer
- Paola Marignani, PhD, EMBA
Targeting CCR4 in CAR-Associated Peripheral T-Cell Lymphoma
Targeting CCR4 in CAR-Associated Peripheral T-Cell Lymphoma
Project Oncology®
Targeting CCR4 in CAR-Associated Peripheral T-Cell Lymphoma
Mutational Complexity in ROS1-Positive mNSCLC: Insights from Real-World Practice
Mutational Complexity in ROS1-Positive mNSCLC: Insights from Real-World Practice
Project Oncology®
Mutational Complexity in ROS1-Positive mNSCLC: Insights from Real-World Practice
Targeting Inflammation to Improve Gene Therapy Outcomes in Sickle Cell Disease
Targeting Inflammation to Improve Gene Therapy Outcomes in Sickle Cell Disease
Clinician's Roundtable
Targeting Inflammation to Improve Gene Therapy Outcomes in Sickle Cell Disease
Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
Project Oncology®
Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
- George Laliotis, MD, MPH, MHA
Stratifying ICI-P Risk in Non-Small Cell Lung Cancer with Genetic and Radiographic Markers
Stratifying ICI-P Risk in Non-Small Cell Lung Cancer with Genetic and Radiographic Markers
Project Oncology®
Stratifying ICI-P Risk in Non-Small Cell Lung Cancer with Genetic and Radiographic Markers
Advances in Prostate Cancer Care: Genetic Testing, Teamwork, and ARPIs
Advances in Prostate Cancer Care: Genetic Testing, Teamwork, and ARPIs
On the Frontlines of Prostate Cancer
Advances in Prostate Cancer Care: Genetic Testing, Teamwork, and ARPIs
- Neal Shore, MD, FACS
mCRPC Care: Predicting Outcomes with a Novel Cell-Free DNA Sequencing Assay
mCRPC Care: Predicting Outcomes with a Novel Cell-Free DNA Sequencing Assay
Global Oncology Academy
mCRPC Care: Predicting Outcomes with a Novel Cell-Free DNA Sequencing Assay
- Scott Dehm, PhD
Epigenetics in the Environment: An Exploration of Genetics & Chronic Health Conditions
Epigenetics in the Environment: An Exploration of Genetics & Chronic Health Conditions
Clinician's Roundtable
Epigenetics in the Environment: An Exploration of Genetics & Chronic Health Conditions
- Hector O. Chapa, MD, FACOG
- Julio M. Jimenez
How Social Determinants Impact Cancer Outcomes: Insights from ASCO 2021
How Social Determinants Impact Cancer Outcomes: Insights from ASCO 2021
Project Oncology®
How Social Determinants Impact Cancer Outcomes: Insights from ASCO 2021
Exploring EGFR Mutations in Lung Cancer: Key Diagnostic & Management Strategies
Exploring EGFR Mutations in Lung Cancer: Key Diagnostic & Management Strategies
Project Oncology®
Exploring EGFR Mutations in Lung Cancer: Key Diagnostic & Management Strategies
- Jacob Sands, MD
- Pasi Antero Jänne, MD, PhD